EGFR and ovarian carcinoma: To investigate that, we analysed the activation status of JAK2/STAT3 in ovarian carcinoma specimens and correlated that to STAT3 activation in two ovarian cancer cell lines directly by EGFR or indirectly through IL-6R activation.